Home > News > Nanobac Pharmaceuticals Inc. Announces Agreement
August 24th, 2006
Nanobac Pharmaceuticals Inc. Announces Agreement
Abstract:
Nanobac Pharmaceuticals, Inc. (OTCBB: NNBP) today announced that it has entered into an agreement and
started work on an animal model to validate a proof of concept that calcifying nanoparticles (CNPs), also known as nanobacteria, promote gallstones. If the proof is validated, it will solve the ages-old mystery of what provokes black pigment gallstones affecting millions of persons, and forge a path to effective early diagnosis and therapy where none are presently available. Results are expected by year-end 2006. Because these gallstones contain material similar to that in kidney stones and breast cancer calcifications, the results could apply to other unsolved calcification-related conditions as well. (PDF)
Source:
Nanobac Pharmaceuticals
Related News Press |
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||